Item 1. Security and Issuer.
This Amendment No. 5 (Amendment No. 5) amends and supplements the statement on Schedule 13D filed by the Reporting Person on
February 4, 2019, as previously amended by Amendment No. 1 filed by the Reporting Person on February 1, 2021, Amendment No. 2 filed by the Reporting Person on February 1, 2022, Amendment No. 3 filed by the Reporting
Person on May 2, 2022 and Amendment No. 4 filed by the Reporting Person on March 3, 2023 (the Original Statement), relating to the common units (the Common Units) representing limited partnership interests of
USA Compression Partners, LP, a Delaware limited partnership (the Issuer), with principal executive offices at 111 Congress Avenue, Suite 2400, Austin, Texas 78701.
Except as specifically provided herein, this Amendment No. 5 does not modify any of the information previously reported on the Original Statement.
Capitalized terms used but not otherwise defined in this Amendment No. 5 shall have the meanings ascribed to them in the Original Statement.
Item 2. Identity and Background.
No change.
Item 3. Source and Amount of Funds or Other Consideration.
Item 3 of this Schedule 13D is hereby amended to include the following:
On October 27, 2023, the Reporting Person exercised in full its warrant (the Exercised Warrant) to acquire 8,413,281 Common Units at an
exercise price of $19.59 per Common Unit. The Exercised Warrant was settled in accordance with the terms of the Exercised Warrant using the net unit settlement method. The description of the exercise of the Exercised Warrant set forth in Item 4 of
this Amendment No. 5 is hereby incorporated by reference into this Item 3.
Item 4. Purpose of Transaction.
Item 4 of this Schedule 13D is hereby amended to include the following:
On October 27, 2023, the Reporting Person exercised the Exercised Warrant to acquire an aggregate of 8,413,281 Common Units using the net unit settlement
method, pursuant to which the Issuer withheld an aggregate of 6,427,336 Common Units, valued at $25.64 per Common Unit pursuant to the terms of the Exercised Warrant, in satisfaction of the aggregate exercise price of the Exercised Warrant.